Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in patients with recurrent high-grade neuroendocrine cervical cancer: a Neuroendocrine Cervical Tumor Registry (NeCTuR) study

Michael Frumovitz, Gary B. Chisholm, Anuja Jhingran, Preetha Ramalingam, Alejandra Flores Legarreta, Priya Bhosale, Naomi R. Gonzales, R. Tyler Hillman, Gloria Salvo